Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer

By Marx D.   Meden H.   Ziemek T.   Lenthe T.   Kuhn W.   Schauer A.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 845-850

Elsevier

Access to resources Recommend Favorite

Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression - a review of the evidence

By Downing S.R.   Jackson P.   Russell P.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 3, 2001-05 ,pp. : 103-110

Elsevier

Access to resources Recommend Favorite

Detection of Serum Anti-p53 Antibodies from Patients with Ovarian Cancer in China: Correlation to Clinical Parameters

By Qiu Tian   Yang Qiong   Li Xing-rong   Yang Hua   Qiu Lin-lin   Wang Li  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 563-568

Informa Healthcare

Access to resources Recommend Favorite

Spectrum of p53 Tumor Suppressor Gene Mutations and Breast Cancer Survival

By Lai Hong  

Breast Cancer Research and Treatment, Vol. 83, Iss. 1, 2004-01 ,pp. : 57-66

Springer Publishing Company

Access to resources Recommend Favorite

Detection of TP53 Gene Mutations in Human Sarcomas

By Castresana J.S.   Rubio M.-P.   Gomez L.   Kreicbergs A.   Zetterberg A.   Barrios C.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 735-738

Elsevier

Access to resources Recommend Favorite